Homehealthcare News

    Zydus begins human trials for potential COVID-19 vaccine

    Zydus begins human trials for potential COVID-19 vaccine

    Zydus begins human trials for potential COVID-19 vaccine
    Profile image

    By Reuters  IST (Updated)

    Mini

    ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated in the pre-clinical toxicity studies, Zydus said

    Indian pharmaceutical company Zydus said on Wednesday it has started human studies for its potential COVID-19 vaccine, as coronavirus infections continue to surge in the world's third worst-hit nation.
    ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated in the pre-clinical toxicity studies, Zydus said
    Also Read
    In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India.
    Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
    arrow down

      Most Read

      Market Movers

      View All
      CompanyPriceChng%Chng